Advertisement

Tumor Biology

, Volume 36, Issue 11, pp 8553–8558 | Cite as

RETRACTED ARTICLE: Clinical significance of CUL4A in human prostate cancer

  • Gang Liu
  • Zengjun Zhu
  • Fang Lang
  • Bao Li
  • Dianjun Gao
Research Article

Abstract

Aberrant expression of the Cullin 4A (CUL4A) is found in many tumor types, but the functions and mechanism of CUL4A in prostate cancer (PCa) development and progression remain largely unknown. The aim of this study was to investigate the possible role of CUL4A in prostate tumorigenesis. Immunohistochemistry was used to examine CUL4A expression in human PCa tissues and BPH tissues. Cell proliferation was assessed by MTT, and migration and invasion were analyzed by Transwell and Matrigel assays after CUL4A knockdown in PCa in vitro. The results showed that CUL4A protein was overexpressed in 86.21 % of PCa tissues. CUL4A knockdown with siRNA in PCa cells decreased cell proliferation, migration, and invasion. Mechanistically, CUL4A could modulate the expression of P53 in PCa cells. Our results indicate that CUL4A overexpression play an oncogenic role in the pathogenesis of PCa, and CUL4A may be a potential therapeutic target for PCa.

Keyword

Prostate cancer CUL4A P53 Proliferation Targeted therapy 

Notes

Conflicts of interest

None.

References

  1. 1.
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.CrossRefPubMedGoogle Scholar
  2. 2.
    Zhang L, Yang BX, Zhang HT, Wang JG, Wang HL, et al. Prostate cancer: an emerging threat to the health of aging men in Asia. Asian J Androl. 2011;13:574–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Ma Y, Yang HZ, Dong BJ, Zou HB, Zhou Y, Kong XM, et al. Biphasic regulation of autophagy by miR-96 in prostate cancer cells under hypoxia. Oncotarget. 2014;5(19):9169–82.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Birner P, Schoppmann A, Schindl M, Dinhof C, Jesch B, Berghoff AS, et al. Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J Clin Pathol. 2012;65(6):507–11.CrossRefPubMedGoogle Scholar
  5. 5.
    Lee J, Zhou P. Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol. 2012;2:21.PubMedPubMedCentralGoogle Scholar
  6. 6.
    Sugasawa K. The CUL4 enigma: culling DNA repair factors. Mol Cell. 2009;34:403–4.CrossRefPubMedGoogle Scholar
  7. 7.
    Nag A, Bagchi S, Raychaudhuri P. Cul4A physically associates with MDM2 and participates in the proteolysis of p53. Cancer Res. 2004;64:8152–5.CrossRefPubMedGoogle Scholar
  8. 8.
    Liu L, Lee S, Zhang J, Peters SB, Hannah J, Zhang Y, et al. CUL4A abrogation augments DNA damage response and protection against skin carcinogenesis. Mol Cell. 2009;34:451–60.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Bondar T, Kalinina A, Khair L, Kopanja D, Nag A, Bagchi S, et al. Cul4A and DDB1 associate with Skp2 to target p27Kip1 for proteolysis involving the COP9 signalosome. Mol Cell Biol. 2006;26:2531–9.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Gupta A, Yang LX, Chen L. Study of the G2/M cell cycle checkpoint in irradiated mammary epithelial cells overexpressing Cul-4A gene. Int J Radiat Oncol Biol Phys. 2002;52:822–30.CrossRefPubMedGoogle Scholar
  11. 11.
    Hung MS, Mao JH, Xu Z, Yang CT, Yu JS, Harvard C, et al. Cul4A is an oncogene in malignant pleural mesothelioma. J Cell Mol Med. 2011;15:350–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in nodenegative breast cancer. Anticancer Res. 2007;27:949–52.PubMedGoogle Scholar
  13. 13.
    Li B, Jia N, Kapur R, Chun KT. Cul4A targets p27 for degradation and regulates proliferation, cell cycle exit, and differentiation during erythropoiesis. Blood. 2006;107:4291–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Nishitani H, Shiomi Y, Iida H, Michishita M, Takami T, Tsurimoto T. CDK inhibitor p21 is degraded by a proliferating cell nuclear antigen-coupled Cul4-DDB1Cdt2 pathway during S phase and after UV irradiation. J Biol Chem. 2008;283:29045–52.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    El-Mahdy MA, Zhu Q, Wang QE, Wani G, Praetorius-Ibba M, Wani AA. Cullin 4A-mediated proteolysis of DDB2 protein at DNA damage sites regulates in vivo lesion recognition by XPC. J Biol Chem. 2006;281:13404–11.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2015

Authors and Affiliations

  • Gang Liu
    • 1
  • Zengjun Zhu
    • 1
  • Fang Lang
    • 1
  • Bao Li
    • 1
  • Dianjun Gao
    • 1
  1. 1.Department of UrologyAffiliated Hospital of Weifang Medical UniversityWeifangChina

Personalised recommendations